TEX35

Across TCGA pan-cancer cohorts, TEX35 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated TEX35 data layer compared with 26 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher TEX35 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TEX35 expression acts as an unfavorable survival marker.

HNSC, KIRP, and BLCA are the cancer types where TEX35 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.069	0.768	<.001	24	view →
KIRP	OS	Median	All	0.157	0.704	.005	12	view →
BLCA	DFS	Median	All	0.078	0.594	<.001	9	view →
LIHC	OS	Median	All	0.167	0.704	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

TEX35–HNSC (OS)

Open the HNSC breakdown →